Articles with "csph" as a keyword



Novel serum biomarker of Golgi protein 73 for the diagnosis of clinically significant portal hypertension in patients with compensated cirrhosis

Sign Up to like & get
recommendations!
Published in 2024 at "Journal of Medical Virology"

DOI: 10.1002/jmv.29380

Abstract: Hepatic venous pressure gradient (HVPG) is the gold standard for evaluating clinically significant portal hypertension (CSPH). However, reliable noninvasive methods are limited. Our study aims to investigate the diagnostic value of serum Golgi protein 73… read more here.

Keywords: clinically significant; serum; csph; patients compensated ... See more keywords

Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension.

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of hepatology"

DOI: 10.1016/j.jhep.2020.05.050

Abstract: BACKGROUND Clinically significant portal hypertension (CSPH, HVPG≥10mmHg) persists 24 weeks after sustained virological response (SVR) in up to 78% of patients with HCV-related cirrhosis treated with direct acting antivirals. These patients remain at risk of… read more here.

Keywords: clinically significant; hvpg; csph; portal hypertension ... See more keywords

Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis.

Sign Up to like & get
recommendations!
Published in 2017 at "Gastroenterology"

DOI: 10.1053/j.gastro.2017.07.016

Abstract: BACKGROUND & AIMS Patients with hepatitis C virus-associated cirrhosis and clinical significant portal hypertension (CSPH, hepatic venous pressure gradient [HVPG] 10 mmHg or greater), despite achieving sustained virological response (SVR) to therapy, remain at risk… read more here.

Keywords: therapy; patients hepatitis; hvpg; csph ... See more keywords
Photo by cdc from unsplash

Liver Stiffness Assessed by Ultrasound Shear Wave Elastography from General Electric Accurately Predicts Clinically Significant Portal Hypertension in Patients with Advanced Chronic Liver Disease.

Sign Up to like & get
recommendations!
Published in 2019 at "Ultraschall in der Medizin"

DOI: 10.1055/a-0965-0745

Abstract: PURPOSE  Clinically significant portal hypertension (CSPH) is responsible for most of the complications in patients with cirrhosis. Liver stiffness (LS) measurement by vibration-controlled transient elastography (VCTE) is currently used to evaluate CSPH. Bi-dimensional shear wave… read more here.

Keywords: vcte; csph; elastography; swe ... See more keywords

A novel surgical scheme for hepatectomy in hepatocellular carcinoma patients with clinically significant portal hypertension

Sign Up to like & get
recommendations!
Published in 2024 at "BMC Cancer"

DOI: 10.1186/s12885-024-12535-9

Abstract: Clinically significant portal hypertension (CSPH) seriously affects the feasibility and safety of surgical treatment for hepatocellular carcinoma (HCC) patients. The aim of this study was to establish a new surgical scheme defining risk classification of… read more here.

Keywords: risk; severe phlf; hepatectomy; csph ... See more keywords